BetterLife Pharma Inc C.BETR

Alternate Symbol(s): BETRF

Healthcare Biotechnology

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat anxiety related disorders, including benzodiazepine dependency. It is also developing MM-001, a topical cream formulation of interferon-alpha 2b, which has completed Phase II clinical trials for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation that has completed Phase II clinical trials for the treatment of COVID-19 and other...

CSE:BETR - Post by User

BetterLife Pharma Inc

<< Previous

Bullboard Posts

Next >>

(435)
•••

Post by rixpixon Apr 18, 2024 9:48pm

180 Views

Post# 35997226

Really surprised to see NO ACTION

Thought for sure there would be some action on BETR shares with the Bloom Burton & Co. Healthcare Investor Conference that took place, but nothing.

No volume and no increase in SP.

<< Previous

Bullboard Posts

Next >>

NiCAN attracts capital from junior mining luminary Michael Gentile